Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial of Rilonacept for Treatment of Autoimmune Neurosensory Hearing Loss

NCT02828033 is registered in ClinicalTrials.gov with Stanley Cohen as lead sponsor.

NCT NCT02828033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02828033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial of Rilonacept for Treatment of Autoimmune Neurosensory Hearing Loss
Lead sponsor
Stanley Cohen
Phase
Phase 1
Overall status
Unknown status
Start date
February 1, 2017
Completion date
March 31, 2018
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune neurosensory hearing loss (anshl)